The risk is highest among patients who switch from anti-androgen to GnRH agonist therapy.
The time to PSA progression in men with relapsing or locally advanced PCa was similar with intermittent and continuous androgen deprivation.
PSA doubling time increased from 28 to 76 months in patients performing exercise training.
Small study shows those undergoing radiation therapy had fewer side effects, less fatigue.
Long-term use of the antiarrhythmic drug, however, may decrease the risk of high-grade prostate cancer.
Researchers investigate sexual dysfunction post RT for localized prostate cancer.
More high-grade cancers detected with MRF-TB vs. systematic biopsy in men undergoing primary biopsy.
Relatively few men with atypical small acinar proliferation are found to have high-grade prostate cancer on repeat biopsy.
But whether that's good or bad isn't yet clear
New analysis shows no significant difference in 10-year progression-free and overall survival among men with high-risk prostate cancer.
Large cost variation over 12 years of follow-up due to equipment, visits.
In small study, olaparib targeted gene mutation in men who had failed other therapy.
Radical prostatectomy was associated with a higher biochemical recurrence-free survival rate compared with radiotherapy.
Men who underwent whole-gland cryoablation had an estimated 5-year biochemical progression-free survival rate of 59.1%.
Problems include longer waits, greater need for more care after surgery, and rehospitalization.
Generally, indigenous cancer rates lower, except for lung cancer in men, cervical in women.
In a study, computed tomography revealed soft-tissue metastases in 44% of men at initial diagnosis of metastatic disease.
No reduction in risk of distant metastasis, cancer-related deaths, radiation-linked adverse effects.
It is a risk factor for low-grade disease, however, Swiss investigators find.
Among men with PCa found on biopsy, those with moderate or high cardiovascular risk are twice as likely to have Gleason 7 or higher tumors.
After 2 years, continence, potency, and freedom from recurrence were achieved in almost half of men who had extended pelvic lymph node dissection.
In studies, subsequent use of chemotherapy and concomitant use of abiraterone or enzalutamide did not raise any new safety concerns.
A year after the federal task force came out against routine PSA screening, diagnoses of low-risk PCa decreased by 38% and continued to fall.
TMPRSS2-ERG in peripheral blood mononuclear cells is linked to greater progression risk in men with metastatic CRPC treated with docetaxel.
Biochemical failure rates, however, appear to be better with radiation, single-institution study finds.
Compared with combination treatment, radiation therapy alone was linked with 64% and 83% lower odds of early death and death from cardiac causes among patients with co-existing illnesses.
Findings among veterans flagged for delayed diagnosis of prostate, colorectal cancer.
Rates of adverse pathology varied from 24% for men with more than 2 positive biopsy cores to 45% in men reclassified by Gleason score.
Over 3 years after radical surgery, men who delayed surgery and those who had immediate surgery had similar rates of biochemical recurrence.
This approach is, or should be, the standard of care for locally advanced PCa, some researchers say.
Sign Up for Free e-newsletters
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)